reglab/housing_qa huggingface dataset:
AZ Rev Stat § 36-2453 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2453 - Inspection of premises; violation; injunction

36-2453.  Inspection of premises;  violation;  injunction A. The department shall periodically inspect each location in which laetrile is manufactured,  prepared and packaged in this state to verify compliance with sanitary standards. B. Upon determining that a violation of sanitary standards has occurred at a location in which laetrile is manufactured,  prepared or packaged,  the director shall request the attorney general to seek an injunction in superior court to close the location until compliance with sanitary standards is ensured.
AZ Rev Stat § 36-2511 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2511 - Nomenclature

36-2511.  Nomenclature The controlled substances listed or to be listed in the schedules in sections 36-2512,  36-2513,  36-2514,  36-2515,  36-2516 and 36-2517 or the rules adopted pursuant to this article are included by whatever official,  common,  usual,  chemical or trade name designated.
AZ Rev Stat § 36-2512 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2512 - Substances in schedule I; rules

36-2512.  Substances in schedule I;  rules A. The board shall adopt by rule the schedule I controlled substances listed in 21 Code of Federal Regulations section 1308.11 and section 13-3401 and shall amend the rules,  as necessary,  to reflect any changes in the schedule I controlled substance designations. B. The board may except by rule any compound,  mixture or preparation containing any substance adopted by rule pursuant to this section from the application of all or any part of this chapter if the compound,  mixture or preparation contains one or more active medicinal ingredients and if the admixtures are included therein in combinations,  quantity,  proportion or concentration that vitiates the potential for abuse.
AZ Rev Stat § 36-2513 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2513 - Substances in schedule II; rules

36-2513.  Substances in schedule II;  rules A. The board shall adopt by rule the schedule II controlled substances listed in 21 Code of Federal Regulations section 1308.12 and shall amend the rules,  as necessary,  to reflect any changes in the schedule II controlled substance designations. B. The board may except by rule any compound,  mixture or preparation containing any substance adopted by rule pursuant to this section from the application of all or any part of this chapter if the compound,  mixture or preparation contains one or more active medicinal ingredients and if the admixtures are included therein in combinations,  quantity,  proportion or concentration that vitiates the potential for abuse.
AZ Rev Stat § 36-2514 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2514 - Substances in schedule III; rules; definition

36-2514.  Substances in schedule III;  rules;  definition A. The board shall adopt by rule the schedule III controlled substances listed in 21 Code of Federal Regulations sections 1300.01 and 1308.13 and shall amend the rules,  as necessary,  to reflect any changes in the schedule III controlled substance designations. B. If any person prescribes,  dispenses or distributes an anabolic steroid for human use that has been approved by the United States food and drug administration for the express intent of administration through implants to cattle or other nonhuman species,  the person shall be considered to have prescribed,  dispensed or distributed an anabolic steroid within the meaning of this section. C. The board may except by rule any compound,  mixture or preparation containing any substance adopted by rule pursuant to this section from the application of all or any part of this chapter if the compound,  mixture or preparation contains one or more active medicinal ingredients and if the admixtures are included therein in combinations,  quantity,  proportion or concentration that vitiates the potential for abuse. D. For the purposes of this section,  " anabolic steroid"  means any drug or hormonal substance that is chemically or pharmacologically related to testosterone,  other than estrogens,  progestins,  corticosteroids and dehydroepiandrosterone.
AZ Rev Stat § 36-2515 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2515 - Substances in schedule IV; rules

36-2515.  Substances in schedule IV;  rules A. The board shall adopt by rule the schedule IV controlled substances listed in 21 Code of Federal Regulations section 1308.14 and shall amend the rules,  as necessary,  to reflect any changes in the schedule IV controlled substance designations. B. The board may except by rule any compound,  mixture or preparation containing any substance adopted by rule pursuant to this section from the application of all or any part of this chapter if the compound,  mixture or preparation contains one or more active medicinal ingredients and if the admixtures are included therein in combinations,  quantity,  proportion or concentration that vitiates the potential for abuse.
AZ Rev Stat § 36-2516 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2516 - Substances in schedule V; rules

36-2516.  Substances in schedule V;  rules A. The board shall adopt by rule the schedule V controlled substances listed in 21 Code of Federal Regulations section 1308.15 and shall amend the rules,  as necessary,  to reflect any changes in the schedule V controlled substance designations. B. Any compound or preparation containing the single active ingredient ephedrine or any of its salts is included in schedule V.
AZ Rev Stat § 36-2517 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2517 - United States food and drug administration; approved medication

36-2517.  United States food and drug administration;  approved medication Any compound,  mixture or preparation that contains cannabidiol and that is approved by the United States food and drug administration and rescheduled by the United States drug enforcement administration is a controlled substance for the purposes of this chapter and may be prescribed in this state.
AZ Rev Stat § 36-2518 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2518 - Schedule exemptions; rules

36-2518.  Schedule exemptions;  rules The rules adopted by the board pursuant to sections 36-2512,  36-2513,  36-2514,  36-2515 and 36-2516 may not include any material,  compound,  mixture or preparation that contains any quantity of a controlled substance and that is listed as an exempt substance in 21 Code of Federal Regulations section 1308.22,  1308.24,  1308.26,  1308.32 or 1308.34.
AZ Rev Stat § 36-2521 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2521 - Rules

36-2521.  Rules The board may promulgate necessary and reasonable rules relating to the registration and control of the manufacture,  distribution and dispensing of controlled substances within this state.
AZ Rev Stat § 36-2522 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2522 - Registration requirements

36-2522.  Registration requirements A. Every person who manufactures,  distributes,  dispenses,  prescribes or uses for scientific purposes any controlled substance within this state or who proposes to engage in the manufacture,  distribution,  prescribing or dispensing of or using for scientific purposes any controlled substance within this state must first: 1. Obtain and possess a current license or permit as a medical practitioner as defined in section 32-1901 or as a pharmacy,  pharmacist,  manufacturer or wholesaler pursuant to title 32,  chapter 18.  2. Be a registrant under the federal controlled substances act (P.L. 91-513;  84 Stat. 1242;  21 United States Code section 801 et seq.).  B. A person who is registered under this chapter to manufacture,  distribute,  dispense,  prescribe or use for scientific purposes controlled substances may possess,  manufacture,  distribute,  dispense,  prescribe or use for scientific purposes those substances to the extent authorized by that person's license or permit in conformity with this chapter and title 32,  chapter 18. C. The following persons need not register and may lawfully possess controlled substances under this chapter: 1. An agent or employee of any registered manufacturer,  distributor or dispenser of any controlled substance if he is acting in the usual course of his business or employment. 2. A common or contract carrier or warehouseman or that person's employee whose possession of any controlled substance is in the usual course of business or employment. 3. An ultimate user or a person in possession of any controlled substance pursuant to a lawful order of a medical practitioner or in lawful possession of a schedule V substance. 4. An officer or employee of the department of public safety,  a professional regulatory board established by title 32,  chapter 7,  11,  13,  14,  15,  16,  17,  18,  21,  25 or 29 or the Arizona state board of pharmacy or a peace officer as defined in section 1-215 in the lawful performance of that person's duties. D. The board may waive by rule the requirement for registration of certain manufacturers,  distributors or dispensers if the board finds waiver consistent with the public health and safety or the requirements of the United States drug enforcement administration. E. The board or its designee may inspect the establishment of a registrant or applicant for registration in accordance with the board's regulation if the board or its designee has information that the board or its designee believes would require an on-site inspection.
AZ Rev Stat § 36-2523 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2523 - Records of registrants; inspection; confidentiality

36-2523.  Records of registrants;  inspection;  confidentiality A. Persons registered to manufacture,  distribute or dispense controlled substances under this chapter shall keep records and maintain inventories in conformance with the record keeping and inventory requirements of federal law and title 32,  chapter 18,  and with any additional rules the board issues. Prescription orders must be filed as required by section 36-2525. B. A person who holds a permit to operate a pharmacy issued under title 32,  chapter 18 shall inventory schedule II,  III,  IV and V controlled substances as prescribed by federal law. The permit holder shall conduct this inventory on May 1 of each year or as directed by the Arizona state board of pharmacy. The permit holder shall also conduct this inventory if there is a change of ownership or discontinuance of business or within ten days of a change of a pharmacist in charge. C. These records and inventories shall be open for inspection by peace officers in the performance of their duties. An officer shall not divulge information obtained pursuant to this subsection except in connection with a prosecution,  investigation,  judicial proceeding or administrative proceeding in which the person to whom the information relates is a party.
AZ Rev Stat § 36-2524 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2524 - Order forms

36-2524.  Order forms Controlled substances in schedules I and II shall be distributed by a registrant to another registrant only pursuant to an order form. Compliance with the provisions of federal law respecting order forms shall be deemed compliance with this section.
AZ Rev Stat § 36-2531 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2531 - Prohibited acts; classification

36-2531.  Prohibited acts;  classification A. It is unlawful for any person: 1. Who is subject to article 3 of this chapter to intentionally or knowingly distribute or dispense a controlled substance in violation of section 36-2525. 2. Who is a registrant to intentionally or knowingly manufacture a controlled substance not authorized by that person's registration or to intentionally or knowingly distribute or dispense a controlled substance not authorized by that person's registration to another registrant or other authorized person. 3. To intentionally or knowingly refuse or fail to make,  keep or furnish any record,  notification,  order form,  statement,  invoice or information required under this chapter. 4. To intentionally or knowingly refuse entry into any premises for any inspection authorized by this chapter. 5. To knowingly dispense or deliver anabolic steroids without a written prescription or for a nontherapeutic use. 6. To intentionally or knowingly sell,  buy,  exchange or give away any preparation subject to section 36-2516 or the rules adopted pursuant to section 36-2516,  unless the preparation is to be used for a legitimate medical purpose and in compliance with this chapter. B. Notwithstanding any other law,  any person who violates any provision of subsection A of this section is guilty of a class 4 felony. C. It is unlawful for any person intentionally or knowingly: 1. To distribute as a registrant a controlled substance classified in schedule I or II,  except pursuant to an order form as required by section 36-2524. 2. To furnish false or fraudulent material information in,  or omit any material information from,  any application,  report or other document required to be kept or filed under this chapter or any record required to be kept by this chapter. D. A person who violates any provision of subsection C of this section is guilty of a class 4 felony. E. A person shall not provide a false prescription for a controlled substance or knowingly or intentionally acquire or obtain possession of a controlled substance by means of forgery,  fraud,  deception or subterfuge,  including the forgery or falsification of a prescription or the nondisclosure of a material fact. A person who violates this subsection is guilty of a class 4 felony. F. Controlled substances,  vehicles and items used or intended for use in violation of this chapter are subject to seizure and forfeiture in the manner provided in title 13,  chapter 39.
AZ Rev Stat § 36-2542 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2542 - Cooperation of agencies

36-2542.  Cooperation of agencies A. The board and department shall cooperate with federal and other state agencies in discharging responsibilities concerning traffic in controlled substances and in suppressing the abuse of controlled substances,  including the dissemination of information to law enforcement agencies relating to any person who is known to have violated or who is suspected of violating this chapter to obtain a controlled substance in violation of section 36-2531. B. Results,  information and evidence received from the United States drug enforcement administration relating to the regulatory functions of this chapter,  including results of inspections conducted by it,  may be relied and acted upon by the board or department in the exercise of its regulatory functions under this chapter.
AZ Rev Stat § 36-2543 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2543 - Review

36-2543.  Review All final civil determinations,  findings and conclusions of the board or the department under this chapter are final and conclusive unless appealed pursuant to title 12,  chapter 7,  article 6.
AZ Rev Stat § 36-2551 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2551 - Pending proceedings

36-2551.  Pending proceedings All administrative proceedings pending under prior laws which are superseded by this chapter shall be continued and brought to a final determination in accord with the laws and rules in effect prior to the effective date of this chapter.
AZ Rev Stat § 36-2552 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2552 - Continuation of rules

36-2552.  Continuation of rules Any orders and rules promulgated under any law affected by this chapter and in effect on the effective date of this chapter and not in conflict with it continue in effect until modified,  superseded or repealed.
AZ Rev Stat § 36-2601 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2601 - Definitions

36-2601.  Definitions In this article,  unless the context otherwise requires: 1. " Board"  means the Arizona state board of pharmacy or its designee. 2. " Dispenser"  means a medical practitioner or pharmacy that is authorized to dispense controlled substances. 3. " Licensed health care provider"  means a person who is licensed pursuant to title 32,  chapter 7,  11,  13,  14,  15,  16,  17,  18,  19.1,  25,  29 or 33. 4. " Medical practitioner"  means any person who is licensed and authorized by law to use and prescribe drugs and devices to treat sick and injured human beings or to diagnose or prevent sickness in human beings in this state or any state,  territory or district of the United States. 5. " Patient utilization report"  means all of the following information about a patient that is compiled by the program and disclosed pursuant to section 36-2606: (a) Controlled substances prescription monitoring program data. (b) Clinical alerts and other required alerts or indicators. 6. " Person"  means an individual,  partnership,  corporation or association and the person's duly authorized agents. 7. " Program"  means the controlled substances prescription monitoring program.
AZ Rev Stat § 36-2602 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2602 - Controlled substances prescription monitoring program; contracts; retention and maintenance of records

36-2602.  Controlled substances prescription monitoring program;  contracts;  retention and maintenance of records A. The board shall adopt rules to establish a controlled substances prescription monitoring program. The program shall: 1. Be operated,  monitored and maintained by the board. 2. Be staffed by the board. 3. Include a computerized central database tracking system to track the prescribing,  dispensing and consumption of schedule II,  III,  IV and V controlled substances that are dispensed by a medical practitioner or by a pharmacy that holds a valid license or permit issued pursuant to title 32. The database shall include data from the department of health services that identifies residents of this state who possess a registry identification card issued pursuant to chapter 28.1 of this title. The tracking system shall not interfere with the legal use of a controlled substance for managing severe or intractable pain. 4. Assist law enforcement to identify illegal activity related to prescribing,  dispensing and consuming schedule II,  III,  IV and V controlled substances. 5. Provide information to patients,  medical practitioners and pharmacists to help avoid the inappropriate use of schedule II,  III,  IV and V controlled substances. 6. Be designed to minimize inconvenience to patients,  prescribing medical practitioners and pharmacies while effectuating the collection and storage of information. B. The board may enter into private or public contracts,  including intergovernmental agreements pursuant to title 11,  chapter 7,  article 3,  to ensure the effective operation of the program. Each contractor must comply with the confidentiality requirements prescribed in this article and is subject to the criminal penalties prescribed in section 36-2610. C. The board shall maintain the following records for the following periods of time: 1. A record of dispensing a controlled substance for seven years after the date the controlled substance was dispensed. 2. Affidavits for the purpose of an open investigation by law enforcement for two years. 3. Court orders requesting medical record information in the program for two years. 4. A patient's request of the patient's own prescription history for two years. 5. A prescriber report for two years.
AZ Rev Stat § 36-2603 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2603 - Computerized central database tracking system task force; consultation on electronic prescribing; membership

36-2603.  Computerized central database tracking system task force;  consultation on electronic prescribing;  membership A. The board shall appoint a task force to help it administer the computerized central database tracking system,  to identify educational,  outreach and support services to advance medical practitioners' adoption of electronic prescribing of schedule II controlled substances and pharmacy implementation of section 36-2525 and to consult with regarding recommendations for exceptions to the electronic prescribing requirements prescribed in section 36-2525. The chairperson of the board shall chair the task force. The task force shall include the following members: 1. Pharmacists,  medical practitioners and other licensed health care providers. 2. Representatives of professional societies and associations for pharmacists,  medical practitioners and other licensed health care providers. 3. Representatives of professional licensing boards. 4. Representatives of the Arizona health care cost containment system administration. 5. Representatives of state and federal agencies that have an interest in controlling controlled substances. 6. Criminal prosecutors. 7. Representatives of a health information organization in this state. B. The task force shall meet to establish the procedures and conditions relating to the release of prescription information pursuant to section 36-2604. The task force shall meet at least once each year and at the call of the chairperson.  C. Task force members serve at the pleasure of the board and are not eligible to receive compensation or reimbursement of expenses.
AZ Rev Stat § 36-2605 (2021)
2021 Arizona Revised Statutes|Title 36 - Public Health and Safety|§ 36-2605 - Controlled substances prescription monitoring program fund

36-2605.  Controlled substances prescription monitoring program fund A. The controlled substances prescription monitoring program fund is established consisting of legislative appropriations,  transfers pursuant to section 32-1907 and any grants,  gifts or donations received by the board. The board shall administer the fund. Monies in the fund are continuously appropriated and shall be used to operate the controlled substances prescription monitoring program established pursuant to section 36-2602. B. The board may apply for grants and may accept gifts,  grants or donations for the establishment and maintenance of the computerized prescription monitoring program.